Details
Stereochemistry | ACHIRAL |
Molecular Formula | C20H30N2O3 |
Molecular Weight | 346.4638 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCOC(=O)C1(CCN(CCN2CCOCC2)CC1)C3=CC=CC=C3
InChI
InChIKey=JDEDMCKQPKGSAX-UHFFFAOYSA-N
InChI=1S/C20H30N2O3/c1-2-25-19(23)20(18-6-4-3-5-7-18)8-10-21(11-9-20)12-13-22-14-16-24-17-15-22/h3-7H,2,8-17H2,1H3
Molecular Formula | C20H30N2O3 |
Molecular Weight | 346.4638 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Morpheridine is a pethidine analog with strong analgesic activity. Morpheridine does not cause convulsions, although it produces the standard opioid side effects such as sedation and respiratory depression. Morpheridine is not currently used in medicine and is a Schedule I drug which is controlled under United Nations drug conventions.
Originator
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:13:37 GMT 2025
by
admin
on
Mon Mar 31 18:13:37 GMT 2025
|
Record UNII |
1854GKB41Y
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C241
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
||
|
DEA NO. |
9632
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB09071MIG
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
61121
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
m1209
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | Merck Index | ||
|
469-81-8
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
207-422-6
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
1854GKB41Y
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
Morpheridine
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
100000080371
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
675
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
CHEMBL2105058
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
DTXSID20196979
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY | |||
|
C66201
Created by
admin on Mon Mar 31 18:13:37 GMT 2025 , Edited by admin on Mon Mar 31 18:13:37 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |